A very nice video summary of the breast cancer Phase I results for CLN. Worth a look:
Celsion Corporation's Side-Effect Free Treatment Shows Success
You are invited to watch a video news release about Celsion Corporation's (CLN) unique, leading edge APA (Adaptive Phased Array) heat-focused technology. In this video you will hear from Surgeon Robert Gardner, M.D. FACS, of the Breast Care Center at Columbia Hospital, nurse practitioner Paula Greene and Clinical Trial patient Geralyn Kaye, on the promise of a new kinder, gentler breast cancer treatment.
What: Video News Release
Heat Alone Kills Breast Cancer
Celsion Corporation First To Finish Successful
Phase I Clinical Trials With Unique Adaptive Phased Array
Technology
When: Beginning Tuesday, November 28, 2000 at 6 a.m. EST
Where: videonewswire.com
Celsion Corporation (CLN) of Columbia Maryland was founded in 1982 by Augustine Cheung, PhD to develop medical treatments for cancer and BPH, (benign prostatic hyperplasia). This breakthrough technology uses minimally-invasive deep focused heat developed by Alan Fenn, PhD of the Massachusetts Institute of Technology.
Celsion has the exclusive rights to the Adaptive Phased Array (APA) system which provides the means of focusing heat on a tumor without burning or overheating the skin and surrounding healthy tissues.
CONTACT:
John Mon
Celsion Corporation www.celsion.com
410-290-5390
john@celsion.com |
